The Role of ANGPTL Gene Family Members in Hepatocellular Carcinoma

Overview

Journal Dis Markers

Publisher Wiley

Specialty Biochemistry

Date 2022 Jun 13

PMID 35692877

Authors

Yun Bai

Dan Lu

Di Qu

Yiwen Li

Ning Zhao

Guanghua Cui

Xue Li

Xiaoke Sun

Yanying Liu

Meiqi Wei

Yu Yang

Affiliations

Soon will be listed here.

Abstract

Background: Hepatocellular carcinoma (HCC) is highly aggressive with a poor prognosis and survival rate. Certain ANGPTL members have been implicated in tumor progression. However, the relevance of the ANGPTL gene family to HCC remains poorly understood. In this study, we explored the role of ANGPTLs in the prognosis of HCC.

Methods: From the CCLE database, we studied the expression of ANGPTLs in a range of cancer cell lines. The UCSC, HCCDB, and Human Protein Atlas databases were used to analyze the differences in mRNA and protein expression of ANGPTLs in HCC tissues. Additionally, the correlation between ANGPTL mRNA and methylation levels and clinicopathological features were assessed in the TCGA database. The correlation between ANGPTL mRNA and overall survival was determined by the Kaplan-Meier plotter. cBioPortal database was used to analyze ANGPTL genomic alterations. Genes associated with ANGPTLs were determined by enrichment with KEGG. Moreover, the differentially expressed genes of ANGPTLs were analyzed by the LinkedOmics database, and the KEGG pathway and miRNA targets of ANGPTLs were also enriched.

Results: There was a significant correlation between the ANGPTL members (excluding ANGPTL2) and the prognosis of HCC patients according to the Kaplan-Meier plotter analysis ( < 0.05). ANGPTL1 was the gene with the highest mutation frequency. ANGPTLs are involved in certain pathways that may influence the development of HCC.

Conclusion: In summary, the expression of some members of ANGPTLs was significantly correlated with HCC prognosis, suggesting that the ANGPTL gene family members may be promising molecular markers for HCC treatment and prognosis.

Citing Articles

ANGPTL3 overcomes sorafenib resistance via suppression of SNAI1 and CPT1A in liver cancer.

Lin Y, Chen C, Chi H, Wu M, Lai M, Yeh C Transl Oncol. 2024; 52():102250.

PMID: 39708716 PMC: 11732165. DOI: 10.1016/j.tranon.2024.102250.

Role of the angiopoietin-like protein family in the progression of NAFLD.

Su X, Xu Q, Li Z, Ren Y, Jiao Q, Wang L Heliyon. 2024; 10(7):e27739.

PMID: 38560164 PMC: 10980950. DOI: 10.1016/j.heliyon.2024.e27739.

Correlation Between the Levels of ANGPTL3, ANGPTL4, ANGPTL8 and Postprandial Triglyceride-Rich Lipoprotein (TRL).

Zhang T, Hou Y, Liu M, Hou X, Tang Y, Ren L Diabetes Metab Syndr Obes. 2023; 16:3979-3993.

PMID: 38084361 PMC: 10710803. DOI: 10.2147/DMSO.S438757.

An Efficient Binary Sand Cat Swarm Optimization for Feature Selection in High-Dimensional Biomedical Data.

Pashaei E Bioengineering (Basel). 2023; 10(10).

PMID: 37892853 PMC: 10604175. DOI: 10.3390/bioengineering10101123.

Pregnancy Toxemia in Ewes: A Review of Molecular Metabolic Mechanisms and Management Strategies.

Ji X, Liu N, Wang Y, Ding K, Huang S, Zhang C Metabolites. 2023; 13(2).

PMID: 36837768 PMC: 9961611. DOI: 10.3390/metabo13020149.

References

Chen E, Tang C, Peng K, Cheng X, Wei Y, Liu T . ANGPTL6-mediated angiogenesis promotes alpha fetoprotein-producing gastric cancer progression. Pathol Res Pract. 2019; 215(8):152454. DOI: 10.1016/j.prp.2019.152454. View

Thorin-Trescases N, Thorin E . High Circulating Levels of ANGPTL2: Beyond a Clinical Marker of Systemic Inflammation. Oxid Med Cell Longev. 2017; 2017:1096385. PMC: 5613648. DOI: 10.1155/2017/1096385. View

Allan C, Larsson M, Jung R, Ploug M, Bensadoun A, Beigneux A . Mobility of "HSPG-bound" LPL explains how LPL is able to reach GPIHBP1 on capillaries. J Lipid Res. 2016; 58(1):216-225. PMC: 5234724. DOI: 10.1194/jlr.M072520. View

Takeshita Y, Motohara T, Kadomatsu T, Doi T, Obayashi K, Oike Y . Angiopoietin-like protein 2 decreases peritoneal metastasis of ovarian cancer cells by suppressing anoikis resistance. Biochem Biophys Res Commun. 2021; 561:26-32. DOI: 10.1016/j.bbrc.2021.05.008. View

Gao L, Ge C, Fang T, Zhao F, Chen T, Yao M . ANGPTL2 promotes tumor metastasis in hepatocellular carcinoma. J Gastroenterol Hepatol. 2014; 30(2):396-404. DOI: 10.1111/jgh.12702. View

Dong X, Pang X, Yu S, Su Y, Wang H, Yin Y . Identification of genes differentially expressed in human hepatocellular carcinoma by a modified suppression subtractive hybridization method. Int J Cancer. 2004; 112(2):239-48. DOI: 10.1002/ijc.20363. View

Yang Y, Deng L, Li X, Shi Z, Chen D, Chen X . Evaluation of the prognosis of fulminant viral hepatitis in late pregnancy by the MELD scoring system. Eur J Clin Microbiol Infect Dis. 2012; 31(10):2673-8. DOI: 10.1007/s10096-012-1613-y. View

El-Shal A, Zidan H, Rashad N, Wadea F . Angiopoietin-like protein 3 and 4 expression 4 and their serum levels in hepatocellular carcinoma. Cytokine. 2017; 96:75-86. DOI: 10.1016/j.cyto.2017.03.006. View

Kolb R, Kluz P, Tan Z, Borcherding N, Bormann N, Vishwakarma A . Obesity-associated inflammation promotes angiogenesis and breast cancer via angiopoietin-like 4. Oncogene. 2018; 38(13):2351-2363. PMC: 6440811. DOI: 10.1038/s41388-018-0592-6. View

10.

Zhu P, Goh Y, Chin H, Kersten S, Tan N . Angiopoietin-like 4: a decade of research. Biosci Rep. 2012; 32(3):211-9. DOI: 10.1042/BSR20110102. View

11.

Worns M, Weinmann A, Schuchmann M, Galle P . Systemic therapies in hepatocellular carcinoma. Dig Dis. 2009; 27(2):175-88. DOI: 10.1159/000218351. View

12.

Chen H, Kuo T, Tseng C, Ma J, Yang S, Yen C . Angiopoietin-like protein 1 antagonizes MET receptor activity to repress sorafenib resistance and cancer stemness in hepatocellular carcinoma. Hepatology. 2016; 64(5):1637-1651. DOI: 10.1002/hep.28773. View

13.

Li X, Ma L, Yang Y, Shi Z, Zhou S . [Prognostic factors of fulminant hepatitis in pregnancy]. Chin Med J (Engl). 2005; 118(20):1754-7. View

14.

Wang L, Geng T, Guo X, Liu J, Zhang P, Yang D . Co-expression of immunoglobulin-like transcript 4 and angiopoietin-like proteins in human non-small cell lung cancer. Mol Med Rep. 2014; 11(4):2789-96. DOI: 10.3892/mmr.2014.3029. View

15.

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

16.

Chen H, Xiao Q, Hu Y, Chen L, Jiang K, Tang Y . ANGPTL1 attenuates colorectal cancer metastasis by up-regulating microRNA-138. J Exp Clin Cancer Res. 2017; 36(1):78. PMC: 5467265. DOI: 10.1186/s13046-017-0548-7. View

17.

Yan Q, Jiang L, Liu M, Yu D, Zhang Y, Fang S . Interacts with Integrin α1β1 to Suppress HCC Angiogenesis and Metastasis by Inhibiting JAK2/STAT3 Signaling. Cancer Res. 2017; 77(21):5831-5845. DOI: 10.1158/0008-5472.CAN-17-0579. View

18.

Huang D, Sun G, Hao X, He X, Zheng Z, Chen C . ANGPTL2-containing small extracellular vesicles from vascular endothelial cells accelerate leukemia progression. J Clin Invest. 2020; 131(1). PMC: 7773400. DOI: 10.1172/JCI138986. View

19.

Siegel R, Miller K, Jemal A . Cancer statistics, 2015. CA Cancer J Clin. 2015; 65(1):5-29. DOI: 10.3322/caac.21254. View

20.

Li H, Ge C, Zhao F, Yan M, Hu C, Jia D . Hypoxia-inducible factor 1 alpha-activated angiopoietin-like protein 4 contributes to tumor metastasis via vascular cell adhesion molecule-1/integrin β1 signaling in human hepatocellular carcinoma. Hepatology. 2011; 54(3):910-9. DOI: 10.1002/hep.24479. View